Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[An open non-comparative study of impase for treating erectile dysfunction].

E B Mazo, S I Gamidov, R I Ovchinnikov

    Urologiia (Moscow, Russia : 1999)
    |July 9, 2003
    PubMed
    Summary

    Impase demonstrated significant clinical efficacy and safety for treating erectile dysfunction (ED) in men. The treatment showed a 60-66.7% efficacy rate with no reported side effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Prognostic ability of seminal plasma lipidomic analysis in predicting the success of microTESE in men with azoospermia].

    Urologiia (Moscow, Russia : 1999)·2022
    Same author

    [The use of a complex of natural antimicrobial peptides and cytokines for treatment of male infertility and chronic prostatitis].

    Urologiia (Moscow, Russia : 1999)·2022
    Same author

    [Evaluation of the efficacy of dapoxetine in primary and secondary forms of premature ejaculation].

    Urologiia (Moscow, Russia : 1999)·2022
    Same author

    [The efficiency of combined regimens for the treatment of urinary tract infections in women using the herbal drug Canephron N].

    Urologiia (Moscow, Russia : 1999)·2021
    Same author

    [Assessment of the safety and efficacy of medicinal product PPR-001 based on regulatory polypeptides of the testes].

    Urologiia (Moscow, Russia : 1999)·2021
    Same author

    [Evaluation of the clinical efficacy of urethroplasty after failed hypospadias repair].

    Urologiia (Moscow, Russia : 1999)·2020

    Area of Science:

    • Urology
    • Pharmacology
    • Men's Health

    Background:

    • Erectile dysfunction (ED) affects a significant number of men, impacting quality of life.
    • Understanding the efficacy and safety of novel therapeutic agents is crucial for managing ED.
    • Impase is a potential treatment option for ED, necessitating clinical evaluation.

    Purpose of the Study:

    • To assess the clinical efficacy and safety of the drug Impase in patients with erectile dysfunction.
    • To determine the treatment response rates based on patient-reported outcomes and clinical assessments.
    • To evaluate Impase's effectiveness across different etiologies of ED.

    Main Methods:

    • A study involving 30 male patients diagnosed with erectile dysfunction of various causes.
    • Treatment involved administering Impase 1 tablet every other day for 12 weeks.
    • Efficacy was measured using the IIED questionnaire, andrological examinations, and laboratory tests.

    Main Results:

    • The mean "erectile function" score improved significantly after 12 weeks of Impase treatment.
    • Overall treatment efficacy ranged from 60% to 66.7%, with excellent, good, or satisfactory responses observed in 66.7% of patients.
    • No adverse side effects were reported, indicating excellent tolerance and safety.

    Conclusions:

    • Impase therapy shows promising efficacy and excellent safety for treating erectile dysfunction.
    • The drug's cost-effectiveness, absence of side effects, and suitability for concurrent therapy make it an advantageous treatment option.
    • Impase offers a viable therapeutic strategy for managing ED, with benefits across different patient subgroups.

    Related Experiment Videos